Teun P. de Boer

Teun P. de Boer

Auto-generated profile, based on publicly available information

Teun P. de Boer

Department of Medical Physiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in Stem Cell Research
Verified
Journal Article
Closed access
MGMarie-José Goumans
Marie-José Goumans
TBTeun P. de Boer
Teun P. de Boer
ASAnke Smits
Anke Smits
LLLinda W. van Laake
Linda W. van Laake
PVPatrick van Vliet
Patrick van Vliet
PDPieter A. Doevendans
Pieter A. Doevendans

1 March 2018 in Pharmacology & Therapeutics
Verified
Journal Article
Open access
BGBirgit Goversen
Birgit Goversen
MHMarcel A.G. van der Heyden
Marcel A.G. van der Heyden
TVToon A.B. van Veen
Toon A.B. van Veen
TBTeun P. de Boer
Teun P. de Boer
Preclinical drug screens are not based on human physiology, possibly complicating predictions on cardiotoxicity. Drug screening can be humanised with in vitro assays using human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). However, in contrast to adult ventricular cardiomyocytes, iPSC-CMs beat spontaneously due to presence of the pacemaking current If and reduced densities of the hyperpolarising current IK1. In adult cardiomyocytes, IK1 finalises repolarisation by stabilising the resting membrane potential while also maintaining excitability. The reduced IK1 density contributes to proarrhythmic traits in iPSC-CMs, which leads to an electrophysiological phenotype that might bias drug responses. The proarrhythmic traits can be suppressed by increasing IK1 in a balanced manner. We systematically evaluated all studies that report strategies to mature iPSC-CMs and found that only few studies report IK1 current densities. Furthermore, these studies did not succeed in establishing sufficient IK1 levels as they either added too little or too much IK1. We conclude that reduced densities of IK1 remain a major flaw in iPSC-CMs, which hampers their use for in vitro drug screening.

1 July 2016 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Open access
RJRoss H. Johnstone
Ross H. Johnstone
ECEugene T.Y. Chang
Eugene T.Y. Chang
RBRémi Bardenet
Rémi Bardenet
TBTeun P. de Boer
Teun P. de Boer
DGDavid J. Gavaghan
David J. Gavaghan
GMGary Richard Mirams
Gary Richard Mirams
Cardiac electrophysiology models have been developed for over 50years, and now include detailed descriptions of individual ion currents and sub-cellular calcium handling. It is commonly accepted that there are many uncertainties in these systems, with quantities such as ion channel kinetics or expression levels being difficult to measure or variable between samples. Until recently, the original approach of describing model parameters using single values has been retained, and consequently the majority of mathematical models in use today provide point predictions, with no associated uncertainty. In recent years, statistical techniques have been developed and applied in many scientific areas to capture uncertainties in the quantities that determine model behaviour, and to provide a distribution of predictions which accounts for this uncertainty. In this paper we discuss this concept, which is termed uncertainty quantification, and consider how it might be applied to cardiac electrophysiology models. We present two case studies in which probability distributions, instead of individual numbers, are inferred from data to describe quantities such as maximal current densities. Then we show how these probabilistic representations of model parameters enable probabilities to be placed on predicted behaviours. We demonstrate how changes in these probability distributions across data sets offer insight into which currents cause beat-to-beat variability in canine APs. We conclude with a discussion of the challenges that this approach entails, and how it provides opportunities to improve our understanding of electrophysiology.

1 May 2012 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MJMalin K.B. Jonsson
Malin K.B. Jonsson
MVMarc A. Vos
Marc A. Vos
GMGary Richard Mirams
Gary Richard Mirams
GDGöran Duker
Göran Duker
PSPeter Sartipy
Peter Sartipy
TVToon A.B. van Veen
Toon A.B. van Veen

14 August 2015 in Circulation Research
Verified
Journal Article
Closed access
MLMei-Ling Chang Liao
Mei-Ling Chang Liao
TBTeun P. de Boer
Teun P. de Boer
HMHiroki Mutoh
Hiroki Mutoh
NRNour Raad
Nour Raad
CRClaudia Richter
Claudia Richter
WZWolfram-Hubertus Zimmermann
Wolfram-Hubertus Zimmermann
Rationale:: Monitoring and controlling cardiac myocyte activity with optogenetic tools offer exciting possibilities for fundamental and translational cardiovascular research. Genetically encoded voltage indicators may be particularly attractive for minimal invasive and repeated assessments of cardiac excitation from the cellular to the whole heart level. Objective:: To test the hypothesis that cardiac myocyte–targeted voltage-sensitive fluorescence protein 2.3 (VSFP2.3) can be exploited as optogenetic tool for the monitoring of electric activity in isolated cardiac myocytes and the whole heart as well as function and maturity in induced pluripotent stem cell–derived cardiac myocytes. Methods and Results:: We first generated mice with cardiac myocyte–restricted expression of VSFP2.3 and demonstrated distinct localization of VSFP2.3 at the t-tubulus/junctional sarcoplasmic reticulum microdomain without any signs for associated pathologies (assessed by echocardiography, RNA-sequencing, and patch clamping). Optically recorded VSFP2.3 signals correlated well with membrane voltage measured simultaneously by patch clamping. The use of VSFP2.3 for human action potential recordings was confirmed by simulation of immature and mature action potentials in murine VSFP2.3 cardiac myocytes. Optical cardiograms could be monitored in whole hearts ex vivo and minimally invasively in vivo via fiber optics at physiological heart rate (10 Hz) and under pacing-induced arrhythmia. Finally, we reprogrammed tail-tip fibroblasts from transgenic mice and used the VSFP2.3 sensor for benchmarking functional and structural maturation in induced pluripotent stem cell–derived cardiac myocytes. Conclusions:: We introduce a novel transgenic voltage-sensor model as a new method in cardiovascular research and provide proof of concept for its use in optogenetic sensing of physiological and pathological excitation in mature and immature cardiac myocytes in vitro and in vivo.

17 April 2018 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
KBKylie A. Beattie
Kylie A. Beattie
AHAdam P. Hill
Adam P. Hill
RBRémi Bardenet
Rémi Bardenet
YCYi Cui
Yi Cui
JVJamie Vandenberg
Jamie Vandenberg
GMGary Richard Mirams
Gary Richard Mirams
Key points: Ion current kinetics are commonly represented by current–voltage relationships, time constant–voltage relationships and subsequently mathematical models fitted to these. These experiments take substantial time, which means they are rarely performed in the same cell. Rather than traditional square‐wave voltage clamps, we fitted a model to the current evoked by a novel sum‐of‐sinusoids voltage clamp that was only 8 s long. Short protocols that can be performed multiple times within a single cell will offer many new opportunities to measure how ion current kinetics are affected by changing conditions. The new model predicts the current under traditional square‐wave protocols well, with better predictions of underlying currents than literature models. The current under a novel physiologically relevant series of action potential clamps is predicted extremely well. The short sinusoidal protocols allow a model to be fully fitted to individual cells, allowing us to examine cell–cell variability in current kinetics for the first time. Understanding the roles of ion currents is crucial to predict the action of pharmaceuticals and mutations in different scenarios, and thereby to guide clinical interventions in the heart, brain and other electrophysiological systems. Our ability to predict how ion currents contribute to cellular electrophysiology is in turn critically dependent on our characterisation of ion channel kinetics – the voltage‐dependent rates of transition between open, closed and inactivated channel states. We present a new method for rapidly exploring and characterising ion channel kinetics, applying it to the hERG potassium channel as an example, with the aim of generating a quantitatively predictive representation of the ion current. We fitted a mathematical model to currents evoked by a novel 8 second sinusoidal voltage clamp in CHO cells overexpressing hERG1a. The model was then used to predict over 5 minutes of recordings in the same cell in response to further protocols: a series of traditional square step voltage clamps, and also a novel voltage clamp comprising a collection of physiologically relevant action potentials. We demonstrate that we can make predictive cell‐specific models that outperform the use of averaged data from a number of different cells, and thereby examine which changes in gating are responsible for cell–cell variability in current kinetics. Our technique allows rapid collection of consistent and high quality data, from single cells, and produces more predictive mathematical ion channel models than traditional approaches.